Aeluma, Inc. (ALMU) is a Goleta, California-based semiconductor company developing compound-semiconductor photonics for AI datacom, sensing, defense, and quantum applications. Three current, attributable analyst targets form the basis of the $21 central figure used here: Freedom Capital Markets holds a Buy rating with a $25 target (lowered from $30 in September 2026), Craig-Hallum reiterates a Buy with a $22 target, and Northland initiated coverage with an Outperform rating and a $16 target. The arithmetic mean of these three figures is $21, with a low-to-high range of $16 to $25.
That range is wide, and it tells the real story. All three analysts see meaningful upside from current levels, but they disagree sharply on magnitude. The more cautious view (Northland, $16) reflects the reality that Aeluma is still transitioning away from government R&D contracts toward commercial sales. The more bullish figures ($22 and $25) place greater weight on the company's scalable non-indium-phosphide manufacturing approach, its CHIPS Act engagement, and the large projected market for photonics in AI data centers. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Aeluma closed at $7.58 on November 12, 2026, giving the stock a market capitalization near $139 million. Its 52-week range is $5.87 to $31.79, which highlights how volatile the shares have been as investors reprice an early-stage company shifting its strategy. Reaching $21 from $7.58 would require a gain of roughly 177%, a very large move that would likely demand not just improving sentiment but concrete evidence of commercial traction.
The path toward such a level would probably run through customer design wins and non-recurring engineering (NRE) agreements, qualification of its high-speed photodetectors and quantum dot lasers, and progress on converting a CHIPS Act letter of intent into a definitive funding agreement. Because the company is pre-profit and generating only modest contract revenue, valuation is driven far more by milestones and narrative than by current earnings multiples.
Several verified developments underpin the bull case. Aeluma has signed a letter of intent for up to $30 million in proposed CHIPS and Science Act funding to advance its scalable photonics platform. It has executed strategic agreements with Sumitomo Chemical Advanced Technologies for wafer production and with AIXTRON for a 200 mm-capable MOCVD (metalorganic chemical vapor deposition) system to expand manufacturing. Management cites expanding customer discussions tied to an anticipated 2028–2032 AI infrastructure buildout, and the company held roughly $53.9 million in cash as of September 30, 2026, providing runway to fund development.
The obstacles are substantial and verified. First-quarter fiscal 2027 revenue fell to about $0.6 million from $1.4 million a year earlier, and the net loss widened to $3.8 million, or $0.19 per share. Full fiscal 2026 revenue declined to roughly $4.46 million. Freedom Capital Markets specifically noted that the company did not provide a fiscal 2027 revenue range, citing that omission as a reason for its target cut. Execution risk in commercializing photonics, competition from larger players such as Lumentum and Coherent, and the possibility that design wins convert to volume more slowly than bulls expect are all meaningful hurdles.
The stock trades far below its 52-week high of $31.79 and near the lower end of its range, with the $5.87 low acting as a key long-term support area. The shares would need to reclaim the psychological $10 level and then the mid-teens before the $21 target becomes a live technical consideration. Until a sustained base forms above the recent lows, the long-term structure remains defined more by recovery potential than by confirmed breakout.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual firms do not always state the exact window. Investors should monitor the conversion of the CHIPS Act letter of intent into a definitive agreement, new customer or NRE announcements, quarterly revenue trajectory, and whether management begins providing forward revenue guidance. Sumitomo and AIXTRON milestone progress and broader AI-datacom capital spending will also matter. From what I see, tracking these milestones closely will be essential.
I often turn to Tickeron’s AI Daily Buy/Sell Signals to monitor names like this one. The tool applies artificial intelligence to scan thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on market conditions and technical behavior. For a volatile, news-sensitive stock, it helps surface opportunities and track shifting trends more efficiently than manual reviews alone, supporting my own analysis process without replacing it.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Aroon Indicator for ALMU entered a downward trend on November 11, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 159 similar instances where the Aroon Indicator formed such a pattern. In 147 of the 159 cases the stock moved lower. This puts the odds of a downward move at 90%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ALMU as a result. In 71 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALMU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ALMU's RSI Oscillator exited the oversold zone, 14 of 14 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 32 of 39 cases where ALMU's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for ALMU just turned positive on October 29, 2026. Looking at past instances where ALMU's MACD turned positive, the stock continued to rise in 38 of 44 cases over the following month. The odds of a continued upward trend are 86%.
Following a +24.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALMU advanced for three days, in 113 of 137 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
ALMU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.365) is normal, around the industry mean (5.443). P/E Ratio (-13.442) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (53.191) is also within normal values, averaging (46.468).
The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. ALMU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALMU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Semiconductors